High educational performance is a distinctive feature of bipolar disorder: a study on cognition in bipolar disorder, schizophrenia patients, relatives and controls
Year: 2015
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Schizophrenia is associated with lower intelligence and poor educational performance relative to the general population. This is, to a lesser degree, also found in first-degree relatives of schizophrenia patients. It is unclear whether bipolar disorder I (BD-I) patients and their relatives have similar lower intellectual and educational performance as that observed in schizophrenia. METHOD: This cross-sectional study investigated intelligence and educational performance in two outpatient samples [494 BD-I patients, 952 schizophrenia spectrum (SCZ) patients], 2231 relatives of BD-I and SCZ patients, 1104 healthy controls and 100 control siblings. Mixed-effects and regression models were used to compare groups on intelligence and educational performance. RESULTS: BD-I patients were more likely to have completed the highest level of education (odds ratio 1.88, 95% confidence interval 1.66-2.70) despite having a lower IQ compared to controls (β = -9.09, S.E. = 1.27, p < 0.001). In contrast, SCZ patients showed both a lower IQ (β = -15.31, S.E. = 0.86, p < 0.001) and lower educational levels compared to controls. Siblings of both patient groups had significantly lower IQ than control siblings, but did not differ on educational performance. IQ scores did not differ between BD-I parents and SCZ parents, but BD-I parents had completed higher educational levels. CONCLUSIONS: Although BD-I patients had a lower IQ than controls, they were more likely to have completed the highest level of education. This contrasts with SCZ patients, who showed both intellectual and educational deficits compared to healthy controls. Since relatives of BD-I patients did not demonstrate superior educational performance, our data suggest that high educational performance may be a distinctive feature of bipolar disorder patients.
Source: Psychological Medicine
Authors: A. Vreeker, M. P. M. Boks, L. Abramovic, S. Verkooijen, A. H. van Bergen, M. H. J. Hillegers, A. T. Spijker, E. Hoencamp, E. J. Regeer, R. F. Riemersma-Van der Lek, A. W. M. M. Stevens, P. F. J. Schulte, R. Vonk, R. Hoekstra, N. J. M. van Beveren, R. W. Kupka, R. M. Brouwer, C. E. Bearden, J. H. MacCabe, R. A. Ophoff, GROUP Investigators
Institutions: University Medical Center Utrecht, PsyQ, Leiden University, Parnassia Groep, Altrecht GGZ, University Medical Center Groningen, University of Groningen, Dimence, Reinier van Arkel, Erasmus MC, Amsterdam UMC Location Vrije Universiteit Amsterdam, University of California, Los Angeles, King's College London
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Eli Lilly and Company, AstraZeneca, University of Cambridge, Universiteit Maastricht, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, GGZ inGeest, Rivierduinen, GGZ Friesland, GGZ Drenthe, Universitair Medisch Centrum Groningen, Universiteit Antwerpen, H. Lundbeck A/S, National Institute of Mental Health, Cilag
OpenAlex ID: W2183431278
